Inactive

Amendment to a Previous Combined Solicitation Page 1 of Amendment to a Previous Combined Solicitation Page 31 of 31 Amendment to a Previous Combined Solicitation *= Required Field Amendment to a Previ... Amendment to a Previous Combined Solicitation Page 1 of Amendment to a Previous Combined Solicitation Page 31 of 31 Amendment to a Previous Combined Solicitation *= Required Field Amendment to a Previous Combined Solicitation Page 1 of 31 The Amended Sections are as follows: The required documented physical operations address, within a 45-minute drive time (during normal traffic volume), where these Doses will be fulfilled has been removed in its entirety from the Statement of Work (SOW). On page 8 of the initially posted Combined Synopsis, the Performance Period has been included as No. 9. Also, on page 8, within the Quotation Evaluation and Award Section, the Government will award a Firm Fixed Price IDIQ Contract and NOT a Firm Fixed Price Requirements Contract. In addition, since pricing for 153 Sm Therapy is dependent on current Market Pricing, we are not requesting that pricing. On page 16 of the initially posted Combined Synopsis, FAR 52.216-1, Type of Contract, was added. FAR 52.232-2 Service of Protest was corrected to read FAR 52.233-2, Service of Protest. The Fill Ins are now also included. On pages 17-18 of the initially posted Combined Synopsis, FAR 52.216-18, Ordering, FAR 52.216-19, Ordering Limitations, and FAR 52.216-22 Indefinite Quantity, the Fill Ins are now included. On page 18 of the initially posted Combined Synopsis, FAR 52.217-7, Option for Increased Quantity-Separately Priced Line Item and FAR 52.217-8 Option to Extend Services have been added. The below Amended Combined Synopsis incorporates the above-mentioned Amended Sections: This is a combined synopsis/solicitation for commercial items prepared in accordance with (IAW) the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The Government reserves the right to make no award from this solicitation.   This is a request for quote (RFQ), and the solicitation number is 36C25021Q0839. The Government anticipates awarding a firm-fixed price IDIQ contract resulting from this solicitation. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circulars 2021-05, effective 03/10/2021. The associated NAICS Code is 325412, Pharmaceutical Preparation Manufacturing.   The Department of Veterans Affairs, Network Contracting Office 10, is soliciting quotes from all sources to supply the Cleveland VA Medical Center Radiopharmaceutical Isotopes for patient care. Respondents to this solicitation must fully demonstrate their capability by supplying detailed quote information, along with any other documents necessary to support the requirements below. Offerors are reminded that representatives from your company SHALL NOT contact any Cleveland VAMC personnel to discuss this RFQ during the solicitation and evaluation process. All questions and concerns regarding this solicitation shall be directed to the Contracting Officer. Questions must be in writing, sent to Gina P. Crank @ gina.crank@va.gov and received no later than September 10, 2021 by 5:00 PM EST. Quotes are to be provided to Gina P. Crank, Contracting Officer, via email at gina.crank@va.gov, no later than September 15,  2021, by 5:00 PM EST. No telephone calls will be accepted. No submission received after the above-mentioned date and time will be accepted.  STATEMENT OF WORK (SOW): The VA Northeast Ohio Healthcare System, Cleveland, OH (VA) has a requirement for Radiopharmaceutical Isotopes (non-fluorodeoxyglucose F 18 agents), for patient care. The Contractor is to provide Unit Dose Radiopharmaceutical products as listed herein, as requested by authorized VA Staff, in accordance with Public Law 104-262 and 38 USC 8153 in order to support the VA. This is a competitive Request for Quote (RFQ) that will be evaluated under FAR Part 12 and 13. DELIVERIES: Deliveries to VA shall be made to: VA Northeast Ohio Healthcare System Nuclear Medicine Service Basement, Room BC-470 10701 East Blvd, Mail Code 115(W) Cleveland, OH 44106 Contractor will provide products for routine (non-emergent) and emergent orders (aka Emergencies). Emergencies are requests placed during and outside of regular work hours (Monday through Friday 6:30 am to 4:30 pm) requiring delivery within 120 minutes after receipt of phoned, electronic, or faxed orders from VA. VA requires prompt processing of Tc-99m tagged WBC Orders, White Blood Cell Count (aka WBC s). 1) DELIVERY and DELIVERY SCHEDULE: Delivery will be made for the same times indicated in this contract to the above listed location under the following conditions: The first delivery in the morning shall be no later than 6:30am, ET, Monday-Friday. If a second delivery is required, it shall arrive by 10:30am, ET. Deliveries will be made to the Nuclear Medicine Hot Lab-BC446, or as otherwise specified, for all radiopharmaceuticals. Access to Nuclear Medicine during non-business hours shall be obtained by contacting VA Police Service. All packaging of radioactive materials SHALL BE clearly labeled RADIOACTIVE on the outside of the shipping carton and comply with all applicable regulating agencies. The Contractor shall perform all quality control procedures as required by Federal and State regulatory agencies. Additional delivery requests for routine orders for same day delivery shall arrive at an agreed upon time when the request is placed. The Contractor shall be required, as deemed necessary by the Cleveland VAMC, to furnish such services as specified, on Federal Holidays and during Non-working hours. All charges incurred for routine orders shall be included in the FEE schedule, to include FUEL SURCHARGES. WBC s are initiated by the Contractor first picking up a blood sample at VA and transporting it to the Contractor s Facility. When the processing is complete, the Contractor returns the processed sample to VA. The time from pickup to return shall not exceed 3.5 hours in total, to minimize inconvenience to the patient, ensure the sample remains viable, reduce delay in care, and help eliminate overtime costs of VA staff. Delivery personnel will be bonded by the contractor. Delivery personnel will wear picture identification while in the medical center. The picture identification will be visible at all times. Contractor shall provide evidence of special driver s licenses required for transporting hazardous materials. Contractor must provide waste disposal at no additional charge of used radioactive dose syringes, vials, etc. All waste shall be picked up with the next scheduled delivery. All radiopharmaceuticals shall be delivered in properly shielded containers. Shipping containers and their labeling must comply with all federal and state regulations. There will be a mechanism to disinfect the shielded containers (pigs) between uses. Any recalled/incorrectly delivered dose for any reason shall be credited for the full amount. All doses shall be delivered to the Cleveland VAMC with a dose security seal to indicate any tampering. The contractor shall provide a daily packing slip accompanying all dose shipments sent the Nuclear Medicine Service for all orders placed. It is the Contractor s responsibility to provide the VA with recall notices on any product that has been delivered to the VA that may be defective. Notification shall be made to the Contracting Officer Representative via the most expedient method. Any doses deemed below standard by the facility shall be credited toward the account. Below standard doses include doses missing appropriate labels, wet or damaged product, product not containing the ordered dose (not within 10 % variance), and other issues that are outside of the generally and widely accepted norms for the industry. The VA will be closed on Federal Holidays. These include: -New Year s Day -Martin Luther King s Birthday -President's Day -Memorial Day -Juneteenth Day -Independence Day -Labor Day -Columbus Day -Veterans Day -Thanksgiving -Christmas Day -Any other day declared a Federal Holiday by the US President. Contractor shall provide any additional technical support deemed necessary by VA for the technical staff, physicians, patient education, etc. All radiopharmaceuticals shall be calibrated and labeled with concentration, calibration time, total volume, total activity and expiration time and date. The contractor will calibrate all doses to ensure proper activity within the range of +/- ten (10) percent of the specified ordered dose per specified requirements based on guidelines outlined in 10 CFR Part 35. All technetium products shall be tested for molybdenum contamination and the amount of molybdenum present shall be stated. The contractor shall ensure that all doses provided are compounded and calibrated by or under the supervision of a certified Nuclear Pharmacist and that all doses will be compounded within required guidelines of the Board of Pharmacy, specifically USP<797> and USP<825> as appropriate. Product information including supplier's source of radiopharmaceuticals, package inserts, results of quality control testing performed by supplier and copies of supplier's license and procedures shall be provided upon request at no additional charge. Consultation service regarding radiopharmaceutical applications, problems, controls, etc., shall be provided upon request at no charge. 2) SCOPE: Quantities expressed in the schedule are estimates based on historical usage for one year. However, quantities and types of radiopharmaceuticals may vary based on patient demand. All radiopharmaceuticals and pharmaceuticals or kits are to be furnished by the Contractor in strict accordance with the terms and conditions of the contract and all applicable local, state, and federal laws. The Contractor is to follow generally accepted standard practices for the industry and regulation for the preparation, transportation, and delivery of Radiopharmaceuticals.  These may include but are not limited to the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Food and Drug Administration (FDA), Nuclear Regulatory Commission (NRC), Center for Disease Control (CDC), United States Pharmacopeia (USP), and Joint Commission (JC). Contractor/supplier shall abide by (CFR 10) Title Code of Federal Regulations, which states: a Licensee may use for medical use only: By-product material manufactured, labeled, packaged, and distributed in accordance with a license issued pursuant to the regulations in Title 10, Code of Federal Regulations, Part 35 and the equivalent regulations of an Agreement State. Reagent kits that have been manufactured, labeled, packed, and distributed in accordance with the approval by the Commission pursuant to S32.73 or an Agreement State under equivalent regulations for the preparation of radiopharmaceuticals for medical use. Pre-calibrated doses should not expire within 4 hours of calibration time requested by VA. The Contractor shall label all supplies as to the amount of radiopharmaceutical, preparation time, expiration time, date, etc., and provide a bar code label to facilitate scanning data into a nuclear medicine information management system. Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radioactive drug, Rx number and calibration time. Each syringe shield and vial shield must also be labeled unless the label on the syringe or vial is visible when shielded. The Contractor shall have available an adequate supply of the contract products to meet the requirements of the facility listed above at its distribution points. If the ordered radiopharmaceutical cannot be delivered to the VA when needed due to a supply, production, or other issue, the Contractor will notify the VA as soon as possible to minimize the impact on Veteran care. The Contractor will obtain the needed dose(s) from another source, including another Radiopharmacy, to be delivered as near as possible to the scheduled delivery time, with concurrence of VA. Contractor will work with VA to assist in the implementation of a nuclear medicine laboratory information management software and hardware system. For unforeseen circumstances, the Contractor may only substitute another radiopharmaceutical for the requested one with VA s approval. When this is done, the VA will pay for the lower priced radiopharmaceutical. The Contractor shall meet all Nuclear Regulatory Commission, Department of Transportation, Food and Drug Administration (F.D.A), OSHA and all other Federal and State agency rules and regulations (Federal and State). Contractor shall accept returns for credit under the following conditions: Product(s) shipped in error Product(s) damaged in shipment Concealed shipping damages Recalled product(s) Outdated products in unopened, original container (specifically authorized for return by manufacturer) Contractor shall offer some form of partial credit for unit doses that are not to be used or cancelled. Please describe partial credit process in CDRL 1. Ordering: Contractor will be furnished the name(s) of individuals authorized to purchase against the Contract. Louis Stokes Cleveland VAMC will provide its own Contracting Officer s Representative (COR). 3) PERSONNEL AUTHORIZED TO PLACE ORDERS: The following personnel are authorized to telephone and/or fax radiopharmaceutical orders: Ordering: Contractor will be furnished the name(s) of individuals authorized to purchase against the Contract. VA will provide its own Contracting Officer s Representative (COR). 4) INVOICING: Contracting Officer s Representative (COR) or appointed representative in writing, shall be provided with a copy of invoice at the end of the month for approval before submission to the Department of Veterans Affairs Financial Services Center for processing. Said invoices will be sent the COR via e-mail and then reviewed for accuracy. The contractor will correct any discrepancies identified within 48 hours. A new invoice will be generated and then sent to the COR before invoice is finalized. Contractor shall be paid monthly, in arrears, upon submission of a properly prepared invoice for services/supplies during the period. Contractor shall submit a monthly invoice within 15 days after the end of the month being billed. The invoice will be accurate and include the contract number, date of services, and an itemized listing of charges for each line item. Invoices shall be submitted electronically to the Department of Veterans Affairs Financial Services Center for processing. Contractor shall submit certified invoices monthly. Invoices at a minimum shall show period covered, billing date, name of radiopharmaceutical, prescription number (Rx number), quantity, date, and cost. All doses shall be listed as a separate line item on the invoice. 5) PERFORMANCE/QUALITY: Doses for other customers of Contractor or not intended to be delivered to VA are not to be delivered to VA. This type of incorrect delivery shall not exceed one per contract Quarter. Any doses deemed below standard by the facility shall be credited toward the account and shall not exceed one per Contract Quarter. All doses shall be labelled correctly. The label on the shielded container will match the label on the syringe or vial. It is the Contractor s responsibility to provide the VA with recall notices on any product that has been delivered to the VA that may be defective. Notification shall be made to the Contracting Officer Representative via the most expedient method. All technetium products shall be tested for molybdenum contamination and the amount of molybdenum present shall be stated. Contractor shall provide complete documentation of quality control results upon request. Product information including supplier s source of radiopharmaceuticals, package inserts, results of quality control testing performed by supplier and copies of supplier s license and procedures shall be provided at no additional charge. Contractor will perform quality control on each agent dispensed. Contractor shall perform all quality control procedures as required by Federal and State regulatory agencies. Only those products that pass Quality Control may be sent to the VA Nuclear Medicine Service. The supplier will demonstrate documentation of Quality Control performance of any item upon request of the VA Nuclear Medicine Service. All products are purchased subject to acceptance by the VA, Nuclear Medicine Service. Products that fail to meet Quality Control criteria of Nuclear Medicine will not be accepted. Products will be rejected and may be discarded if found unsatisfactory by the Nuclear Medicine s Quality Control when they are received, or later if deterioration of the product occurs before the expiration date. The VA will not be financially liable for unacceptable materials. Quality Control criteria include but is not limited to: proper labelling of the shielded container and syringe or vial no visible contaminants in the dose dry, clean shielded containers WBC s orders are to have little to no red blood cell contamination intact, undamaged shipping containers, shielded containers and syringe or vial Scan result (incorrect biodistribution) that indicates a poor tag on the radiopharmaceutical All doses and shipping containers shall be equipped with tamper-evident/tamper-resistant devices. 6) QUALIFICATIONS: Personnel assigned by the contractor to perform the services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. The qualifications of such personnel shall also be subject to review by the VA Chief of Staff and approval by VA Facility Director if deemed necessary. 7) PERSONNEL POLICY: Pharmacy personnel shall complete Facility required training for Contractors per VA policy and maintain patient information in the strictest of confidence. 8) MODIFICATION: In accordance with FAR 52.212-4(c), changes may only be made by a written modification which is formally executed by the contractor and the Contracting Officer. 9) PERFORMANCE PERIOD: Performance period will be a 5 Year ordering period with delivery orders issued as needed. No Intent Memo or Modification will be issued annually, only a Delivery Order will be issued as needed. Quotation Evaluation and Award This is a competitive Request for Quotations (RFQ) that will be evaluated under FAR Part 12 and Part 13. The Government intends to make one (1) award from this RFQ.  The Government will award a Firm Fixed Price IDIQ Contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors will be used to evaluate offers: Price Past Performance Technical (capability of offer to meet the Government s needs) Offers should be submitted electronically by email on September 15, 2021 NLT 5:00 PM EST to the Contracting Officer @ gina.crank@va.gov Offers should include the following 3 sections to their offers: A completed Cost/Price Schedule filled in below AND complete the attached Excel Spreadsheet for RFQ Line Items to be completed by Contractors Updated . Please don t provide any pricing for 153 Sm Therapy since the pricing is dependent on current Market Pricing. Also please don t add/quote any additional Medications to the below Cost/Price Schedule. Additional Medications can be stated but please don t include them to your pricing totals. For the purpose of evaluation, the total price including ordering periods will be evaluated. Past Performance to include the following information Identify at least 3 recent (within the past 3 years) Federal, State, local Government or private contracts that are similar in size and scope to this requirement. Dollar Value Dates of performance Name of Agency/Facility Point of Contact along with contact information A brief description of the work effort to demonstrate the relationship between the reference contract and the proposed effort CPARS and PPIRS will be used for evaluation. Technical description in sufficient detail to allow the Government to ascertain the Offeror s capability to meet, in addition to the items listed in the cost/price schedule, the requirements indicated in the SOW and should include at a minimum the following information: Ability to meet the required delivery timeframes. Ability to meet compliance and regulation requirements. Quality control measures. Ability to supply LEU sourced products. Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government. The award will be made based on the quotation determined to be most advantageous to the Government. To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" Quoters shall list exception(s) and rationale for the exception(s), if any. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). Cost/Price Schedule The quantities listed below are yearly estimates only and do not guarantee that the Government will require the total quantities of each item or limit the Government s ability to exceed the quantities. The contractor is to fill in a unit price for each line item and a total price. Any proposed substitute items need to be clearly marked as such and which item the substitution is proposed for. The Guaranteed Minimum for this contract is $1,000.00. The contract ceiling is $5,000,000.00 The Government does not guarantee that it will place any orders under this contract in excess of the guaranteed minimum amount. ITEM INFORMATION VA Cleveland, General Rx - Solicitation Number 36C25021Q0839 Ordering Period 1 10/01/2021 -09/30/2022 Item Est. Qty LEU Price Total Price LEU 99M TC Sulfur Colloid: 1 to 6 Millicurie 200  $ 99M Tc-MDP: 20 Millicurie 850  $ 99M Tc Mebrofenin: 5 to 10 Millicuries 90  $ 99M TC-MAG-3-unit dose: 2 to 15 Millicurie 80  $ 99M Tc-Tetrofosmin (generic): 10 to 35 millicurie 10  $ 99M TC MAA : 4 to 7 Millicurie (fresh eluate - liver mapping) 15  $ 99M TC MAA : 1 to 6 Millicurie 75  $ IN-111 Pentetreotide: 2 to 7 Millicurie 5  $ 99M TC04-: 25 Millicurie 100  $ 99m Tc- Sestamibi (generic): 10 to 35 millicurie 4800  $ 99m Tc- White Blood Cell labeling per study (25 mCi)(Ceretec supplied by VA) 120  $ IN-111 White Blood Cell labeling per study (0.5 to 1 millicurie)(In-111 Oxine supplied by VA) 2  $ 99m TC DTPA: 30 - 40 Millicurie 60  $ 99m TC DTPA: .4 - .7 Millicurie 5  $ I-123: Iodine Capsule 200 Microcuries 150  $ I-123: Iodine Capsule 2 - 5 Millicuries (WB scan) 12  $ ULTRATAG KIT 12  $ 99M Tc-Filtered Sulfur Colloid: 0.5 to 1 Millicurie 6  $ 123I: MIBG dose 2  $ Cold PYP vials 50  $ 99m Tc PYP 35  $ 99m Tc DMSA 2  $ 153Sm Therapy TBD  $ (TBD BY MARKET PRICE) $ 67 Gallium Citrate 3 - 8 mCi 2  $ In 111 DTPA 0.5 - 1.5 mCi 2  $ Thallium Cl 201 1 - 5 mCi 4  $ 99m Tc HMPAO 15 - 20 mCi 2  $ 131I diagnostic capsule 10  $ 131I Therapeutic capsule 1-3 mCi 15  $ 131I Therapeutic capsule each additional mCi 1500  $ Total Ordering Period 1   $   Ordering Period 2 10/01/2022 - 09/30/2023   Item Est. Qty LEU Price Total Price LEU 99M TC Sulfur Colloid: 1 to 6 Millicurie 210  $ 99M Tc-MDP: 20 Millicurie 900  $ 99M Tc Mebrofenin: 5 to 10 Millicuries 95  $ 99M TC-MAG-3-unit dose: 2 to 15 Millicurie 85  $ 99M Tc-Tetrofosmin (generic): 10 to 35 millicurie 12  $ 99M TC MAA : 4 to 7 Millicurie (fresh eluate - liver mapping) 15  $ 99M TC MAA : 1 to 6 Millicurie 80  $ IN-111 Pentetreotide: 2 to 7 Millicurie 5  $ 99M TC04-: 25 Millicurie 105  $ 99m Tc- Sestamibi (generic): 10 to 35 millicurie 4900  $ 99m Tc- White Blood Cell labeling per study (25 mCi)(Ceretec supplied by VA) 125  $ IN-111 White Blood Cell labeling per study (0.5 to 1 millicurie)(In-111 Oxine supplied by VA) 2  $ 99m TC DTPA: 30 to 40 Millicurie 66  $ 99m TC DTPA: .4 - .7 Millicurie 5  $ I-123: Iodine Capsule 200 Microcuries 155  $ I-123: Iodine Capsule 2 - 5 Millicuries (WB scan) 12  $ ULTRATAG KIT 15  $ 99M Tc-Filtered Sulfur Colloid: 0.5 to 1 Millicurie 6  $ 123I: MIBG dose 2  $ Cold PYP vials 50  $ 99m Tc PYP 40  $ 99m Tc DMSA 2  $ 153Sm Therapy TBD  $ (TBD BY MARKET PRICE) $ 67 Gallium Citrate 3 - 8 mCi 2  $ In 111 DTPA 0.5 - 1.5 mCi 2  $ Thallium Cl 201 1 - 5 mCi 4  $ 99m Tc HMPAO 15 - 20 mCi 2  $ 131I diagnostic capsule 10  $ 131I Therapeutic capsule 1-3 mCi 15  $ 131I Therapeutic capsule each additional mCi 1500  $ Total Ordering Period 2   $   Ordering Period 3 10/01/2023 - 09/30/2024   Item Est. Qty LEU Price Total Price LEU 99M TC Sulfur Colloid: 1 to 6 Millicurie 215  $ 99M Tc-MDP: 20 Millicurie 930  $ 99M Tc Mebrofenin: 5 to 10 Millicuries 100  $ 99M TC-MAG-3-unit dose: 2 to 15 Millicurie 90  $ 99M Tc-Tetrofosmin (generic): 10 to 35 millicurie 12  $ 99M TC MAA : 4 to 7 Millicurie (fresh eluate - liver mapping) 15  $ 99M TC MAA : 1 to 6 Millicurie 85  $ IN-111 Pentetreotide: 2 to 7 Millicurie 5  $ 99M TC04-: 25 Millicurie 110  $ 99m Tc- Sestamibi (generic): 10 to 35 millicurie 5000  $ 99m Tc- White Blood Cell labeling per study (25 mCi)(Ceretec supplied by VA) 130  $ IN-111 White Blood Cell labeling per study (0.5 to 1 millicurie)(In-111 Oxine supplied by VA) 2  $ 99m TC DTPA: 30 to 40 Millicurie 70  $ 99m TC DTPA: .4 - .7 Millicurie 5  $ I-123: Iodine Capsule 200 Microcuries 160  $ I-123: Iodine Capsule 2 - 5 Millicuries (WB scan) 12  $ ULTRATAG KIT 15  $ 99M Tc-Filtered Sulfur Colloid: 0.5 to 1 Millicurie 6  $ 123I: MIBG dose 2  $ Cold PYP vials 50  $ 99m Tc PYP 45  $ 99m Tc DMSA 2  $ 153Sm Therapy TBD  $ (TBD BY MARKET PRICE) $ 67 Gallium Citrate 3 - 8 mCi 2  $ In 111 DTPA 0.5 - 1.5 mCi 2  $ Thallium Cl 201 1 - 5 mCi 4  $ 99m Tc HMPAO 15 - 20 mCi 2  $ 131I diagnostic capsule 10  $ 131I Therapeutic capsule 1-3 mCi 15  $ 131I Therapeutic capsule each additional mCi 1500  $ Total Ordering Period 3   $   Ordering Period 4 10/01/2024 - 09/30/2025   Item Est. Qty LEU Price Total Price LEU 99M TC Sulfur Colloid: 1 to 6 Millicurie 220  $ 99M TcMDP: 20 Millicurie 940  $ 99M Tc Mebrofenin: 5 to 10 Millicuries 105  $ 99M TCMAG-3-unit dose: 2 to 15 Millicurie 95  $ 99M TcTetrofosmin (generic): 10 to 35 millicurie 12  $ 99M TC MAA : 4 to 7 Millicurie (fresh eluate - liver mapping) 15  $ 99M Tc MAA : 1 to 6 Millicurie 90  $ IN-111 Pentetreotide: 2 to 7 Millicurie 5  $ 99M Tc04-: 25 Millicurie 110  $ 99m Tc Sestamibi (generic): 10 to 35 millicurie 5000  $ 99m Tc- White Blood Cell labeling per study (25 mCi)(Ceretec supplied by VA) 135  $ IN-111 White Blood Cell labeling per study (0.5 to 1 millicurie)(In-111 Oxine supplied by VA) 3  $ 99m TC DTPA: 30 to 40 Millicurie 70  $ 99m TC DTPA: .4 - .7 Millicurie 5  $ I-123: Iodine Capsule 200 Microcuries 165  $ I-123: Iodine Capsule 2 - 5 Millicuries (WB scan) 12  $ ULTRATAG KIT 7  $ 99M Tc-Filtered Sulfur Colloid: 0.5 to 1 Millicurie 7  $ 123I: MIBG dose 3  $ Cold PYP vials 50  $ 99m Tc PYP 50  $ 99m Tc DMSA 2  $ 153Sm Therapy TBD  $ (TBD BY MARKET PRICE) $ 67 Gallium Citrate 3 - 8 mCi 2  $ In 111 DTPA 0.5 - 1.5 mCi 2  $ Thallium Cl 201 1 - 5 mCi 4  $ 99m Tc HMPAO 15 - 20 mCi 2  $ 131I diagnostic capsule 10  $ 131I Therapeutic capsule 1-3 mCi 15  $ 131I Therapeutic capsule each additional mCi 1500  $ Total Ordering Period 4   $   Ordering Period 5 10/01/2025 - 09/30/2026   Item Est. Qty LEU Price Total Price LEU 99M TC Sulfur Colloid: 1 to 6 Millicurie 103  $ 99M TcMDP: 20 Millicurie 791  $ 99M Tc Mebrofenin: 5 to 10 Millicuries 66  $ 99M TCMAG-3-unit dose: 2 to 15 Millicurie 37  $ 99M TcTetrofosmin (generic): 10 to 35 millicurie 7  $ 99M TC MAA : 4 to 7 Millicurie (fresh eluate - liver mapping) 15  $ 99M Tc MAA : 1 to 6 Millicurie 81  $ IN-111 Pentetreotide: 2 to 7 Millicurie 18  $ 99M Tc04-: 25 Millicurie 110  $ 99m Tc Sestamibi (generic): 10 to 35 millicurie 5200  $ 99m Tc- White Blood Cell labeling per study (25 mCi)(Ceretec supplied by VA) 66  $ IN-111 White Blood Cell labeling per study (0.5 to 1 millicurie)(In-111 Oxine supplied by VA) 3  $ 99m TC DTPA: 30 to 40 Millicurie 70  $ 99m TC DTPA: .4 - .7 Millicurie 5  $ I-123: Iodine Capsule 200 Microcuries 165  $ I-123: Iodine Capsule 2 - 5 Millicuries (WB scan) 12  $ ULTRATAG KIT 7  $ 99M Tc-Filtered Sulfur Colloid: 0.5 to 1 Millicurie 7  $ 123I: MIBG dose 3  $ Cold PYP vials 81  $ 99m Tc PYP 3  $ 99m Tc DMSA 3  $ 67 Gallium Citrate 3 - 8 mCi 2  $ 153Sm Therapy TBD  $ (TBD BY MARKET PRICE) $ In 111 DTPA 0.5 - 1.5 mCi 2  $ Thallium Cl 201 1 - 5 mCi 4  $ 99m Tc HMPAO 15 - 20 mCi 2  $ 131I diagnostic capsule 10  $ 131I Therapeutic capsule 1-3 mCi 15  $ 131I Therapeutic capsule each additional mCi 1500  $ Total Ordering Period 5   $   Total 5 Year Ordering Period   $ The following solicitation provisions apply to this acquisition: FAR 52.212-1, INSTRUCTIONS TO OFFERORS COMMERCIAL ITEMS (JUNE 2020) FAR 52.212-3, OFFERORS REPRESENTATIONS AND CERTIFICATIONS COMMERCIAL ITEMS (FEB 2021) Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://www.sam.gov/portal in accordance with FAR 52.212-3, Offerors Representations and Certifications Commercial Items. If paragraph (j) of the provision is applicable, a written submission is required. FAR 52.216-1 TYPE OF CONTRACT (APR 1984)- Firm Fixed Price IDIQ contract resulting from this solicitation. FAR 52.233-2 SERVICE OF PROTEST (SEPT 2006) - Hand-Carried Address: Department of Veterans Affairs, Network Contracting Office 10, 2780 Airport Drive, Suite 340, Columbus, OH 43219 Mailing Address: Department of Veterans Affairs, Network Contracting Office 10, 2780 Airport Drive, Suite 340, Columbus, OH 43219 (b) The copy of any protest shall be received in the office designated above within one day of filing a protest with the GAO. The following contract clauses apply to this acquisition: FAR 52.212-4, CONTRACT TERMS AND CONDITIONS COMMERCIAL ITEMS (OCT 2018) ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS COMMERCIAL ITEMS Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The following clauses are incorporated into 52.212-4 as an addendum to this contract: FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) FAR 52.203-16 PREVENTING PERSONAL CONFLICTS OF INTEREST (DEC 2011) FAR 52.203-17 CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS (APR 2014) FAR 52.204-4 PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER CONTENT PAPER (MAY 2011) FAR 52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE (JUL 2016) FAR 52.216-18 ORDERING (Aug 2020) - (a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the Schedule. Such orders may be issued from October 1, 2021 through September 30, 2026.       (b) All delivery orders or task orders are subject to the terms and conditions of this contract. In the event of conflict be...